Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ning Lei

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Cancers|February 23, 2020
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer CellsJing-Quan Wang, Jonathan Y Li, Qiu-Xu Teng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2023
Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase InhibitorsSi-Qi Wang, Jun-Jiang Chen, Yuchen Jiang, et al.
Cancers|September 9, 2020
BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug ResistanceYunali V Ashar, Jingchun Zhou, Pranav Gupta, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 8, 2021
Metal (II) Complexes of Fluconazole: Thermal, XRD and Cytotoxicity StudiesSyed Imran Ali, Zi-Ning Lei, Mohsin Ali, et al.
Frontiers in Oncology|July 6, 2019
Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an <i>in vitro</i> StudyNing Ji, Yuqi Yang, Chao-Yun Cai, et al.
Cancer Communications (London, England)|June 12, 2020
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitorYuqi Yang, Ning Ji, Chao-Yun Cai, et al.
Archiv Der Pharmazie|September 30, 2011
Synthesis and biological evaluation of novel homocamptothecins conjugating with dihydropyrimidine derivatives as potent topoisomerase I inhibitorsLingjian Zhu, Pengfei Cheng, Ning Lei, et al.
Frontiers in Cell and Developmental Biology|September 28, 2020
Bruton's Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer CellsXing-Duo Dong, Meng Zhang, Xiubin Ma, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|December 10, 2020
[Effects of organic fertilizer application on flag leaf C/N ratio, photosynthetic characteristics and yield of spring wheat with full plastic film mulching]Jia-de Yin, Hui-Zhi Hou, Xu-Cheng Zhang, et al.
Molecules (Basel, Switzerland)|December 6, 2019
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 ExpressionDan Liao, Wei Zhang, Pranav Gupta, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Cancers|February 23, 2020
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer CellsJing-Quan Wang, Jonathan Y Li, Qiu-Xu Teng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2023
Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase InhibitorsSi-Qi Wang, Jun-Jiang Chen, Yuchen Jiang, et al.
Cancers|September 9, 2020
BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug ResistanceYunali V Ashar, Jingchun Zhou, Pranav Gupta, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 8, 2021
Metal (II) Complexes of Fluconazole: Thermal, XRD and Cytotoxicity StudiesSyed Imran Ali, Zi-Ning Lei, Mohsin Ali, et al.
Frontiers in Oncology|July 6, 2019
Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an <i>in vitro</i> StudyNing Ji, Yuqi Yang, Chao-Yun Cai, et al.
Cancer Communications (London, England)|June 12, 2020
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitorYuqi Yang, Ning Ji, Chao-Yun Cai, et al.
Archiv Der Pharmazie|September 30, 2011
Synthesis and biological evaluation of novel homocamptothecins conjugating with dihydropyrimidine derivatives as potent topoisomerase I inhibitorsLingjian Zhu, Pengfei Cheng, Ning Lei, et al.
Frontiers in Cell and Developmental Biology|September 28, 2020
Bruton's Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer CellsXing-Duo Dong, Meng Zhang, Xiubin Ma, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|December 10, 2020
[Effects of organic fertilizer application on flag leaf C/N ratio, photosynthetic characteristics and yield of spring wheat with full plastic film mulching]Jia-de Yin, Hui-Zhi Hou, Xu-Cheng Zhang, et al.
Molecules (Basel, Switzerland)|December 6, 2019
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 ExpressionDan Liao, Wei Zhang, Pranav Gupta, et al.
Pageof 14